- Home
- VNRX vs ATNM Comparison
VNRX vs ATNM Comparison
Compare VNRX & ATNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNRX
- ATNM
- Stock Information
- Founded
- VNRX N/A
- ATNM 2000
- Country
- VNRX United States
- ATNM United States
- Employees
- VNRX N/A
- ATNM N/A
- Industry
- VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- ATNM Biotechnology: Pharmaceutical Preparations
- Sector
- VNRX Health Care
- ATNM Health Care
- Exchange
- VNRX Nasdaq
- ATNM Nasdaq
- Market Cap
- VNRX 52.4M
- ATNM 51.5M
- IPO Year
- VNRX N/A
- ATNM N/A
- Fundamental
- Price
- VNRX $0.50
- ATNM $1.54
- Analyst Decision
- VNRX Strong Buy
- ATNM Strong Buy
- Analyst Count
- VNRX 4
- ATNM 3
- Target Price
- VNRX $4.17
- ATNM $4.67
- AVG Volume (30 Days)
- VNRX 263.7K
- ATNM 229.8K
- Earning Date
- VNRX 05-15-2025
- ATNM 05-09-2025
- Dividend Yield
- VNRX N/A
- ATNM N/A
- EPS Growth
- VNRX N/A
- ATNM N/A
- EPS
- VNRX N/A
- ATNM N/A
- Revenue
- VNRX $1,308,361.00
- ATNM N/A
- Revenue This Year
- VNRX $563.72
- ATNM N/A
- Revenue Next Year
- VNRX $160.43
- ATNM N/A
- P/E Ratio
- VNRX N/A
- ATNM N/A
- Revenue Growth
- VNRX 64.16
- ATNM N/A
- 52 Week Low
- VNRX $0.40
- ATNM $1.03
- 52 Week High
- VNRX $0.90
- ATNM $8.64
- Technical
- Relative Strength Index (RSI)
- VNRX 52.42
- ATNM 49.81
- Support Level
- VNRX $0.40
- ATNM $1.56
- Resistance Level
- VNRX $0.54
- ATNM $1.69
- Average True Range (ATR)
- VNRX 0.05
- ATNM 0.11
- MACD
- VNRX 0.00
- ATNM -0.01
- Stochastic Oscillator
- VNRX 73.57
- ATNM 32.18
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.
About ATNM Actinium Pharmaceuticals Inc. (Delaware)
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.